James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 6,996 shares at $32.50 ($228K) on 2017-11-02, disclosed to the SEC on 2017-11-08.
Scheduled sale ($228k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.57 | 2,410 | $78K | 34.5% |
| 2 | $32.58 | 1,497 | $49K | 21.4% |
| 3 | $32.59 | 1,710 | $56K | 24.5% |
| 4 | $32.50 | 100 | $3K | 1.4% |
| 5 | $32.51 | 455 | $15K | 6.5% |
| 6 | $32.51 | 824 |
| $27K |
| 11.8% |
| Total | $32.57 avg | 6,996 | $228K | 100% |
| Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-07-09 | $399K | — | Filing → |
| GHDX | SELL | 2019-06-10 | $61K | — | Filing → |